Literature DB >> 2538641

A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system.

A Zurbriggen1, R S Fujinami.   

Abstract

Theiler's murine encephalomyelitis virus infection of mice is an animal model for human demyelinating diseases. To further define the role of this virus in the disease process, we selected a virus variant resistant to neutralization by a monoclonal antibody to VP-1. This virus variant was then injected into SJL/J mice. Central nervous system tissue was compared between variant virus- and wild-type virus-infected mice. Within the brain, no large differences were observed between the two groups as to the distribution of inflammatory infiltrates around the injection site and the number of viral antigen-positive cells during the first weeks of the observation period. In contrast, in the spinal cord major differences were found between variant virus- and wild-type virus-infected mice regarding the number of inflammatory lesions, infected cells, and the size of the areas involved with time. By immunohistochemistry, equivalent numbers of infected cells could be found in the spinal cord 1 week postinfection (p.i.): however, after that time, the number of infected cells in the wild-type virus-infected mice continued to increase, whereas the virus-positive cells from the variant virus-infected mice gradually decreased. Thus, the number of viral antigen-containing cells peaked by 1 week p.i. in the variant virus-infected animals. Conversely, the number of infected cells in the spinal cords from mice inoculated with wild-type virus steadily increased until 8 weeks p.i. At this time (8 weeks p.i.), no more variant virus antigen-positive cells could be observed within the spinal cord. Plaque assay of central nervous system tissue confirmed these differences between the two groups observed by immunohistochemistry. No infectious variant virus could be isolated after 2 weeks p.i. from the brain and 4 weeks p.i. from the spinal cord, whereas infectious wild-type virus could be detected up to the end of the observation period (12 weeks p.i.). Virus which was isolated from variant virus-infected mice still retained the neutralization-resistant phenotype. These studies emphasize the important biological in vivo activity of Theiler's virus VP-1 in determining neurovirulence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538641      PMCID: PMC248382     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response.

Authors:  H L Lipton; F Gonzalez-Scarano
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

2.  Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection.

Authors:  H L Lipton; J Kratochvil; P Sethi; M C Dal Canto
Journal:  Neurology       Date:  1984-08       Impact factor: 9.910

3.  Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants.

Authors:  D R Spriggs; B N Fields
Journal:  Nature       Date:  1982-05-06       Impact factor: 49.962

4.  Identification of an antigenic site in the neutralization of type 3 poliovirus.

Authors:  P D Minor; D M Evans; G C Schild; M Ferguson; J W Almond
Journal:  Rev Infect Dis       Date:  1984 May-Jun

5.  Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence.

Authors:  V I Agol; V P Grachev; S G Drozdov; M S Kolesnikova; V G Kozlov; N M Ralph; L I Romanova; E A Tolskaya; A V Tyufanov; E G Viktorova
Journal:  Virology       Date:  1984-07-15       Impact factor: 3.616

6.  Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.

Authors:  M Chow; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice.

Authors:  R P Roos; R Wollmann
Journal:  Ann Neurol       Date:  1984-05       Impact factor: 10.422

8.  The effect of short-term and chronic immunosuppression on Theiler's virus demyelination.

Authors:  R P Roos; S Firestone; R Wollmann; D Variakojis; B G Arnason
Journal:  J Neuroimmunol       Date:  1982-06       Impact factor: 3.478

9.  Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.

Authors:  D M Evans; P D Minor; G S Schild; J W Almond
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

10.  Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus.

Authors:  H L Lipton; M C Dal Canto
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

View more
  34 in total

1.  Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

2.  Innate but not adaptive immune responses contribute to behavioral seizures following viral infection.

Authors:  Nikki J Kirkman; Jane E Libbey; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  Epilepsia       Date:  2009-10-20       Impact factor: 5.864

3.  Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses.

Authors:  M Rodriguez; R P Roos
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

5.  Infiltrating macrophages are key to the development of seizures following virus infection.

Authors:  Matthew F Cusick; Jane E Libbey; Dipan C Patel; Daniel J Doty; Robert S Fujinami
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

6.  Hemagglutinin mutations related to attenuation and altered cell tropism of a virulent avian influenza A virus.

Authors:  M Philpott; C Hioe; M Sheerar; V S Hinshaw
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Role of sialyloligosaccharide binding in Theiler's virus persistence.

Authors:  L Zhou; X Lin; T J Green; H L Lipton; M Luo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Lymphocyte recognition elements on the VP1 protein of Theiler's virus.

Authors:  E J Usherwood; I C Johnston; L J Lovelidge; P Tonks; A A Nash
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Three-dimensional structure of Theiler virus.

Authors:  R A Grant; D J Filman; R S Fujinami; J P Icenogle; J M Hogle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci.

Authors:  S A Huber; A Moraska; M Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.